Results 181 to 190 of about 3,905,688 (260)

eIF4G2-Dependent Translation Restrains Pancreatic Cancer Progression. [PDF]

Cancer Res
Powers J, Wei L, Cheung JCT, Ahmadi P, Kobayashi H, Curiel-Garcia A, Kang S, Valenzuela E, Jovanovic M, Chavez A, Chio IIC.   +10 more
europepmc   +1 more source

Subsequent breast cancer risk after benign breast biopsy in racially diverse women: Siteman Cancer Center. [PDF]

J Natl Cancer Inst
Koric A, Bennett DL, Boulos F, Colditz GA.   +3 more
europepmc   +1 more source

Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer

Molecular Oncology, EarlyView.
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche, Niels J. van Ruitenbeek, Charlotte Adang, Luke O'Gorman, Pui Yuen Lee, Willemijn M. Klein, Adriana C. H. van Engen‐van Grunsven, Jack A. Schalken, Sander Bervoets, Gerald W. Verhaegh, Carla M. L. van Herpen   +10 more
wiley   +1 more source

Relations in young adults with cancer: acknowledging partners and friends as caregivers-a Danish national study. [PDF]

Support Care Cancer
Christensen ME, Enggaard H, Pappot H, Thisted LB, Carstens LIB, Søby AKH, Lykke T, Johansen MLK, Bergmann MB, Hjerming M, Piil K, Jespersen LH, Simonsen AB, Rosted E, Bentsen L, - on behalf of the Network for Adolescents Young Adults Cancer Research in Denmark (NAYAcare DK).   +15 more
europepmc   +1 more source

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

Molecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi, Tuan Khang Huynh, Adway Kadam, Zahra Kardan, Yue Yan, Amina Jamal Laham, Sampath Kumar Loganathan   +6 more
wiley   +1 more source

NN-01-195, a Novel Conjugate of HSP90 and AURKA Inhibitors, Effectively Targets Solid Tumors. [PDF]

Mol Cancer Ther
Nguyen TT, Nandwana NK, Srikanth YVV, Bagnyukova T, Chkhalo O, Cai KQ, Lamperelli J, Pirestani S, Mehra MK, Burtness BA, Borghaei H, Akunuri R, Cassel J, Lu L, Salvino JM, Golemis EA.   +15 more
europepmc   +1 more source

ADP‐ribosylation: An emerging regulator of the epigenome

Molecular Oncology, EarlyView.
ADP‐ribosylation has emerged as a dynamic epigenetic signaling mechanism that modifies histones and chromatin‐associated proteins. Through coordinated PARylation and MARylation, it integrates with other histone modifications to regulate chromatin structure, transcription factor activity, and gene expression, influencing genome function and disease ...
Cristel V. Camacho, Chenqian Liu, W. Lee Kraus   +2 more
wiley   +1 more source

The Multiethnic Cohort: A Resource for the Study of Genetic and Nongenetic Cancer Risk across Populations. [PDF]

Cancer Epidemiol Biomarkers Prev
Bogumil D, Sheng X, Wan P, Xia L, Pooler L, Cheng I, Streicher SA, Huang BZ, Chen F, Stram DO, Shen J, King G, Chiang CWK, Ongaco CM, Adams M, McMullen I, Zhang P, Ling H, Mawhinney M, Doheny KF, Le Marchand L, Wilkens LR, Haiman CA, Conti DV.   +23 more
europepmc   +1 more source

CANCER

American Journal of Public Health, 1923
openaire   +3 more sources